- Home
- GURE vs APVO Comparison
GURE vs APVO Comparison
Compare GURE & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- APVO
- Stock Information
- Founded
- GURE 2006
- APVO 2016
- Country
- GURE China
- APVO United States
- Employees
- GURE N/A
- APVO N/A
- Industry
- GURE Major Chemicals
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- APVO Health Care
- Exchange
- GURE Nasdaq
- APVO Nasdaq
- Market Cap
- GURE 7.1M
- APVO 6.5M
- IPO Year
- GURE 1992
- APVO N/A
- Fundamental
- Price
- GURE $0.68
- APVO $4.14
- Analyst Decision
- GURE
- APVO Strong Buy
- Analyst Count
- GURE 0
- APVO 1
- Target Price
- GURE N/A
- APVO $296.00
- AVG Volume (30 Days)
- GURE 251.5K
- APVO 60.9K
- Earning Date
- GURE 11-19-2024
- APVO 03-04-2025
- Dividend Yield
- GURE N/A
- APVO N/A
- EPS Growth
- GURE N/A
- APVO N/A
- EPS
- GURE N/A
- APVO N/A
- Revenue
- GURE $12,802,982.00
- APVO N/A
- Revenue This Year
- GURE N/A
- APVO N/A
- Revenue Next Year
- GURE N/A
- APVO N/A
- P/E Ratio
- GURE N/A
- APVO N/A
- Revenue Growth
- GURE N/A
- APVO N/A
- 52 Week Low
- GURE $0.50
- APVO $3.65
- 52 Week High
- GURE $1.79
- APVO $399.60
- Technical
- Relative Strength Index (RSI)
- GURE 49.72
- APVO 36.42
- Support Level
- GURE $0.62
- APVO $4.46
- Resistance Level
- GURE $0.73
- APVO $4.64
- Average True Range (ATR)
- GURE 0.08
- APVO 0.34
- MACD
- GURE -0.00
- APVO 0.09
- Stochastic Oscillator
- GURE 50.00
- APVO 29.59
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.